Carmen Besliu, MD, is Senior Medical Director in Bucharest, Romania. She serves as global lead project physician on clients’ drug development projects and provides medical/scientific expertise to project teams. Dr.
Carlo Lanza, MD, PhD, is Executive Medical Officer for Fortrea, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase I-IV clinical trials for Fortrea clients.
Brian Hamilton, MD, PhD, is Senior Medical Director for Fortrea, based in Newton, Massachusetts. He serves as Fortrea Subject Matter Expert for cellular immune-oncology, CAR-T and gene therapy.
Brian has over 20 years clinical research experience, having worked at biotech companies, a global CRO and GlobalCare Clinical Trials. Brian joined Fortrea in 2020.
Dr. Todorova is a board-certified neurologist with over 15 years of clinical and research experience in neurodegenerative disorders and demyelinating diseases.
Andrea Buschiazzo, MD, MBA, is a Senior Medical Director at Fortrea, a Board-Certified Rheumatologist and a Clinical Pharmacologist (University of Buenos Ares).
With Fortrea, you can save time and money, while ensuring patient safety, regulatory compliance and improving quality and data integrity, and still gain valuable insights about your pharmacovigilance (PV) operations. Learn more here.
